Physician

Caesar Kyle Luo, M.D.

According to 2025 Medicare claims, Caesar Luo, M.D. (NPI: 1669684072) practices ophthalmology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is BAY AREA RETINA ASSOCIATES (NPI: 1174557805; TIN: 94-3064464) and primary practice location at 94589-2567.

Luo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 944 traditional Medicare patients, billed 41,734 HCPCS/CPT codes, and received $2,469,709 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 302 prescription claims across 110 beneficiaries totaling $18,190 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 74 records totaling $118,194. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $819,812 to $2,469,709. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $53,635 and ending at $18,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,070	5,982	$819,812
2016	1,049	6,488	$858,612
2017	1,191	5,847	$850,817
2018	812	7,624	$1,460,778
2019	832	9,077	$2,063,856
2020	727	9,399	$2,362,056
2021	869	10,689	$2,875,375
2022	986	16,850	$3,056,040
2023	820	21,987	$1,847,538
2024	944	41,734	$2,469,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	611	$53,635
2016	229	763	$103,036
2017	224	924	$160,398
2018	130	365	$72,150
2019	110	410	$60,921
2020	116	414	$84,953
2021	126	390	$44,790
2022	137	470	$121,645
2023	106	332	$93,497
2024	110	302	$18,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	291	1,030	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	178	240	$117
92014	Established patient complete exam of visual system	536	660	$113
92012	Established patient problem focused exam of visual system	220	331	$85
92134	Imaging of retina	860	2,050	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	95	4,578	$5,079
Travoprost	Travoprost	13	375	$1,424
Moxifloxacin	Moxifloxacin Hcl	46	773	$1,065
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	45	3,003	$782
Ketorolac Tromethamine	Ketorolac Tromethamine	33	1,505	$654

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$21,755	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$96,439	Ocular Therapeutix, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Caesar Kyle Luo, M.D.?

Tedicare shows public-source Medicare data for Caesar Kyle Luo, M.D. (NPI 1669684072), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Caesar Kyle Luo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Caesar Kyle Luo, M.D.?

Caesar Kyle Luo, M.D. is linked to BAY AREA RETINA ASSOCIATES (billing NPI 1174557805) in the available physician profile data.

Does Caesar Kyle Luo, M.D. have Open Payments data?

Caesar Kyle Luo, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.